An interventional study of Biodex balance system and Short Foot Exercise in Flat Foot, sponsored by Cairo University. Not yet recruiting at 2 sites in Egypt. Open to participants aged 18 Years to 30 Years. Per ClinicalTrials.gov, last updated 2024-09-23.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
The goal of this study is to see the effect of the combination of biodex balance system and short foot exercise in the treatment of subjects with flexible flat foot. The main question is the effect of biodex balance training and short foot exercise on myoelectric activity of subjects with flexible flat foot experimental participant will receive biodex balance system exercise and short foot exercise for 4 weeks controlled participant will receive short foot exercise and stretching exercise for 4 weeks Assessment will be done pre and post treatment by using Navicular drop test Myoelectric activity of paraspinal muscle Dynamic balance Pain severity Functional ankle instability inder
173 studies on the registry are indexed under Flatfoot; 44 are open to participants now.
This study's planned enrollment of 60 is above the median of 40 across 122 interventional studies indexed under Flatfoot.
Browse Flatfoot studies →Cairo University is the lead sponsor of 4,941 studies on the registry; 1,458 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Group A 30 subjects will receive short foot exercise and stretching exercise gastrocnemius, soleus muscle and planter fascia stretch.
Other: Short Foot Exercise
Group B will receive Biodex balance training and short foot exercise.
Device: Biodex balance system · Other: Short Foot Exercise
The Biodex Balance System has a wide range of clinical applications and provides objective measures from testing that can be used to establish progressions and discharge criteria, as well as be part of a comprehensive Fall Risk Assessment or Fall Screening Program. Balance ability can be assessed either statically or dynamically, as well as bilaterally and unilaterally. It also allows for bilateral comparisons between involved and uninvolved limbs.
Short foot exercise is used as a therapeutic exercise to strengthen intrinsic foot muscles and used as training to create an MLA. It helps improve the balance in functional movement of FF subjects, decreases navicular drop (ND) through intrinsic muscle activation, supports navicular stability, and improves balance
Muscle myoelectric activity
myoelectric activity of paraspinal muscles measured by surface electromygraphy
Time frame: 4 weeks
Foot print pressure
Using myopressure force platform to measure average peak planter pressure
Time frame: 4 weeks
Dynamic balance
Biodex balance system will be used to assess balance before and after treatment
Time frame: 4 weeks
Functional ankle instability index
Cumberland Ankle Instability Tool The CAIT is a nine-item questionnaire intended to identify and grade ankle instability
Time frame: 4 weeks
Pain severity
Evaluation of lower back pain severity by using visual analogue scale
Time frame: 4 weeks
Plan to share: Yes
Supporting information: Study protocol
Start is estimated for Oct 2024; primary completion for Feb 2025, 4 months later.
Of 89 non-industry interventional studies with no phase under Flatfoot, half reached primary completion within 7 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 15. This study's planned 4 months is below that.
Counting every sponsor, half of 89 studies reached it within 7 months; a quarter within 2 and three quarters within 15.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Sep 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.